Maharashtra FDA seizes drugs, cosmetics worth ₹34.51 lakh, cancels 122 licences

The FDA conducted 1,986 inspections of drug manufacturing, sales and other regulated establishments during the month and issued 674 notices.

The Maharashtra Food and Drug Administration (FDA) seized drugs and cosmetics worth ₹34.51 lakh, cancelled 122 licences and suspended 422 others following enforcement action across the State in October 2026, according to a press note issued by the department on Thursday (November 5, 2026).

The FDA conducted 1,986 inspections of drug manufacturing, sales and other regulated establishments during the month and issued 674 notices. Of these, 1,694 inspections were conducted at drug sales establishments and 292 at manufacturing and other regulated establishments. The department cancelled 105 licences and suspended 367 licences of sales establishments, while 17 licences were cancelled and 55 suspended in the manufacturing and other categories.

The department also carried out 11 search and seizure operations involving alleged violations related to the manufacture, storage and sale of drugs and cosmetics. Two FIRs were registered, and four persons were arrested under the Narcotic Drugs and Psychotropic Substances (NDPS) Act in connection with the illegal sale of narcotic drugs.

Among the major seizures, FDA officials recovered allopathic drugs worth ₹22.03 lakh from the premises of Phoenix Medicorp in Nagpur on October 7. According to the department, the establishment had stored drugs at unlicensed premises despite surrendering its licences.

In Mumbai, FDA officials seized spurious drugs identified as Empirime tablets and Cardiurex 2 ml, worth ₹1.01 lakh, from INHS Asvini in Colaba on October 29, according to the department.

In separate operations in Chhatrapati Sambhajinagar on October 14 and 25, officials seized 199 Nitrosun 10 tablets containing Nitrazepam. Four persons were arrested in connection with their alleged illegal sale.

The FDA also seized cosmetic soaps worth ₹4.05 lakh from Vedas Herbals Mahila Gruh Udyog in Baramati, Pune district, on October 14, for alleged manufacturing without a licence. In Vasai East, officials seized raw materials, packaging materials and machinery worth ₹1.83 lakh from G.B. Cosmetics on October 10 in connection with alleged unlicensed manufacture and sale of nail polish.

The Konkan division recorded the highest number of inspections in October at 556, followed by Pune with 375 and Greater Mumbai with 322. Konkan also accounted for the highest number of regulatory actions at 156, followed by Greater Mumbai with 105 and Pune with 77.

Between April 1 and October 31, the FDA conducted 7,950 inspections across Maharashtra, issued 2,888 notices, cancelled 555 licences and suspended 2,074 licences. The department recorded 2,629 regulatory actions, comprising licence cancellations and suspensions, during the seven-month period.

The FDA urged citizens to report instances of illegal drug manufacturing or sales, as well as suspected substandard drugs, medical devices and cosmetics, to its commissioner’s office or the nearest district office.